VectivBio AG
Life-transforming medicines for rare diseases
We have a world-class team with deep expertise in rare diseases and a track record of success in Research & Development commercialization and business development for innovative products targeting orphan conditions with major unmet medical needs.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
30.10.2023
Entrepreneur of the Year Award für Urban Connect und VectivBio Gründer (startupticker.ch)
23.05.2023
Ironwood Pharma to acquire VectivBio for more than USD 1 billion (startupticker.ch)
16.03.2023
VectivBio and its partner conduct Japan-centric clinical trial (startupticker.ch)
20.10.2022
VectivBio raises $125 million (startupticker.ch)
05.07.2022
VectivBio Announces Closing of $54 Million Aggregate Financing (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
VectivBio AG
Life-transforming medicines for rare diseases
Website:
vectivbio.com/
Ironwood Pharmaceuticals
Headquarter:
Basel
Foundation Date:
May 2019
Technology:
- Biotech